BCL2 and Kaposi's sarcoma: In agreement with the fact that Bcl-2 expression can lead to inappropriate endothelial cell survival and abnormal angiogenesis [25, 28], clinical evidence suggests that the deregulation of Bcl-2 expression could play a role in the maintenance and progression of KS.